Literature DB >> 16670239

"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.

Joanne E Mantell1, Neetha S Morar, Landon Myer, Gita Ramjee.   

Abstract

OBJECTIVES: We examined perceptions of the effectiveness and acceptability of a candidate microbicide among 94 South African female sex workers who had participated in a phase 3 microbicide trial for HIV prevention.
METHODS: Sixteen focus groups were conducted in 2001, 12 to 15 months after participants were informed that the candidate microbicide had been determined to be ineffective in preventing HIV and other sexually transmitted infections (STIs).
RESULTS: Participants clearly indicated that they understood the experimental nature of the candidate microbicide, and they recognized that they had been informed after the trial that the product was ineffective. Nevertheless, most continued to believe that the candidate microbicide helped prevent HIV and other STIs, alleviated reproductive tract pain and STI symptoms, and helped to clean the vagina.
CONCLUSIONS: These findings underscore the importance of understanding women's perceptions of the efficacy of candidate microbicides and the rationale for these beliefs. These issues need to be addressed in counseling throughout microbicide trials for HIV prevention. These results also demonstrate how desperate many women at high risk of HIV infection may be for new HIV prevention technologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670239      PMCID: PMC1470621          DOI: 10.2105/AJPH.2004.047514

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

Review 1.  Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations.

Authors:  P H Kilmarx; G Ramjee; D Kitayaporn; P Kunasol
Journal:  AIDS       Date:  2001       Impact factor: 4.177

2.  Microbicides to prevent heterosexual transmission of HIV: ten years down the road.

Authors:  Janneke van de Wijgert; Christiana Coggins
Journal:  BETA       Date:  2002

3.  Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world.

Authors:  G Ramjee; N S Morar; M Alary; L Mukenge-Tshibaka; B Vuylsteke; V Ettiègne-Traoré; V Chandeying; S A Karim; L Van Damme
Journal:  AIDS       Date:  2000-11-10       Impact factor: 4.177

4.  The protective effect of nonoxynol-9 against HIV infection.

Authors:  P J Feldblum; S S Weir
Journal:  Am J Public Health       Date:  1994-06       Impact factor: 9.308

Review 5.  Challenges for the development of female-controlled vaginal microbicides.

Authors:  C J Elias; L L Heise
Journal:  AIDS       Date:  1994-01       Impact factor: 4.177

6.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

Review 7.  Microbicide acceptability research: current approaches and future directions.

Authors:  Joanne E Mantell; Landon Myer; Alex Carballo-Diéguez; Zena Stein; Gita Ramjee; Neetha S Morar; Polly F Harrison
Journal:  Soc Sci Med       Date:  2005-01       Impact factor: 4.634

8.  Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials.

Authors:  Anne S Coletti; Patrick Heagerty; Amy R Sheon; Michael Gross; Beryl A Koblin; David S Metzger; George R Seage
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02-01       Impact factor: 3.731

Review 9.  Shifts in condom use following microbicide introduction: should we be concerned?

Authors:  Anna M Foss; Peter T Vickerman; Lori Heise; Charlotte H Watts
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

10.  Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers.

Authors:  Q A Karim; S S Karim; K Soldan; M Zondi
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

View more
  12 in total

1.  Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.

Authors:  Rochelle K Rosen; Jacob J van den Berg; Sara E Vargas; Natali Senocak; Julia G Shaw; Robert W Buckheit; Kelley Alison Smith; Kate Morrow Guthrie
Journal:  Contraception       Date:  2015-08-11       Impact factor: 3.375

2.  User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Authors:  Kathleen M Morrow; Kristen Underhill; Jacob J van den Berg; Sara Vargas; Rochelle K Rosen; David F Katz
Journal:  Arch Sex Behav       Date:  2014-01-23

3.  Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe.

Authors:  Cynthia Woodsong; Patty Alleman; Petina Musara; Adlight Chandipwisa; Mike Chirenje; Francis Martinson; Irving Hoffman
Journal:  AIDS Behav       Date:  2012-04

4.  How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Shelley Lees; Charles Shagi; Stella Kasindi; Selephina Soteli; Natujwa Kavit; Lisa Vallely; Sheena McCormack; Robert Pool; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2010-06-13       Impact factor: 2.652

5.  Microbicidas Metodo de Prevencion en VIH/SIDA Controlado por Mujeres.

Authors:  Cindy Ruiz; Viviana Torres; Rosina Cianelli; Lilian Ferrer
Journal:  Hisp Health Care Int       Date:  2009-03

6.  Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Authors:  Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

7.  Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial.

Authors:  Ariane van der Straten; Helen Cheng; Agnes Chidanyika; Guy De Bruyn; Nancy Padian
Journal:  AIDS Behav       Date:  2010-06

8.  Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?

Authors:  Kristen Underhill
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

9.  Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.

Authors:  Robert L Cook; Julie S Downs; Jeanne Marrazzo; Galen E Switzer; Ozlem Tanriover; Harold Wiesenfeld; Pamela J Murray; Sharon L Hillier
Journal:  J Womens Health (Larchmt)       Date:  2009-08       Impact factor: 2.681

Review 10.  Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.

Authors:  Jennifer L Brown; Jessica M Sales; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.